Skye Bioscience, Inc. (SKYE)
Pharmaceutical Preparations
Latest Price
$2.11
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.23
P/B Ratio
9.29
Institutional Ownership
45.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| 5AM Venture Management, LLC | 9.68M | $6.0M | 27.55% | -- | 2026-06-30 |
| Versant Venture Management, LLC | 2.01M | $1.0M | 5.71% | -- | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 1.58M | $1.0M | 4.48% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 763.9K | -- | 2.17% | -575 | 2026-06-30 |
| SPHERA FUNDS MANAGEMENT LTD. | 678.9K | -- | 1.93% | -- | 2026-06-30 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 233.1K | -- | 0.66% | -- | 2026-06-30 |
| BlackRock, Inc. | 232.9K | -- | 0.66% | -53.3K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 218.1K | -- | 0.62% | -59.2K | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 198.5K | -- | 0.56% | -59.7K | 2026-06-30 |
| CITADEL ADVISORS LLC | 124.0K | -- | 0.35% | +25.1K | 2026-06-30 |